Article feature image

Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2021 Results – Earnings Call Transcript

Stock Analysis

Esperion Therapeutics, Inc. (ESPR) Q2 2021 Earnings Conference Call August 3, 2021 8:00 AM ET
Company Participants
Ben Church – Investor Relations & Corporate Communications
Sheldon Koenig – President & Chief Executive Officer
Joanne Foody – Chief Medical…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts